Neurogenic bladder: the child with spina bifida
Know what to do and when to protect the kidneys in a child with neurogenic bladder, and which changes require urgent assessment.
Step 1 of 11
Objectives
After this course you will be able to
- Explain the causes and risk patterns of neurogenic bladder.
- Plan the initial urologic assessment in a newborn with spina bifida.
- Know the role of clean intermittent catheterization and antimuscarinic treatment.
- Distinguish asymptomatic bacteriuria from febrile infection.
- Recognize the red flags of deterioration.
Key message: the main goal is not dryness but protecting the kidneys. A high-pressure bladder can damage the kidneys without symptoms, so treatment starts early after birth.
Basics
Causes
- Spina bifida (myelomeningocele): the most common cause in children.
- Occult spinal dysraphism, tethered cord, lipomeningocele.
- Sacral agenesis, spinal anomalies associated with anorectal malformations.
- Spinal cord trauma, tumors, transverse myelitis.
- Cerebral palsy and other central nervous system disorders (with lower risk).
A dimple, hair tuft, hemangioma, lipoma or asymmetric gluteal cleft in the lumbosacral area suggests occult spinal dysraphism.
Basics
Risk patterns
| Detrusor | Sphincter | Clinical picture | Renal risk |
|---|---|---|---|
| Overactive | Overactive (detrusor-sphincter dyssynergia) | High pressure, reflux, incomplete emptying | Highest |
| Overactive | Weak | Continuous wetting, relatively low pressure | Moderate |
| Underactive | Overactive | Large volume, residual urine, infection | Moderate to high |
| Underactive | Weak | Wetting, low pressure | Low |
Low compliance (a stiff bladder) and a detrusor leak point pressure above 40 cm H2O are the main risk markers for the upper urinary tract.
Diagnosis
Initial assessment in the newborn
- In the first days: kidney and bladder ultrasound, measurement of postvoid residual urine.
- If the residual is large or there is dilation: start intermittent catheterization immediately.
- Creatinine (maternal creatinine affects the result in the first days, so the trend matters).
- Urodynamic study in the first 2–3 months of life: pressure, compliance, sphincter function.
- VCUG or videourodynamics if there is febrile infection or dilation; DMSA to assess scarring.
Proactive approach: rather than waiting for complications, identify the risk pattern early and start catheterization and antimuscarinic treatment early. This approach reduces kidney damage and the future need for augmentation.
Diagnosis
Follow-up schedule
| Study | Frequency (stable child) |
|---|---|
| Kidney and bladder ultrasound | Every 6 months in the first years, then once a year |
| Urodynamics | Once a year in the first years, then individualized; immediately if symptoms change |
| Creatinine, blood pressure | Once a year |
| DMSA | After a febrile infection or if loss of function is suspected |
Diagnosis
Infection: whom to treat?
- Bacteria and leukocytes are found in the urine of most catheterized children. Without symptoms this is asymptomatic bacteriuria and needs no treatment.
- Routine urine cultures are not sent in a child without symptoms.
- Requires treatment: fever, flank pain, new or increased wetting, blood in the urine, deterioration in general condition.
- If febrile infections recur: reassess catheterization technique and frequency, constipation, reflux and bladder pressure.
Treating asymptomatic bacteriuria is of no benefit and leads to resistant bacteria.
Diagnosis
Red flags
The following changes require prompt assessment by a pediatric urologist and a neurosurgeon:
- New or increasing hydronephrosis, bladder wall thickening on ultrasound.
- Increased wetting in a previously dry child, shorter dry intervals between catheterizations.
- Recurrent febrile infections.
- New leg weakness, change in gait, back pain, rapidly progressing scoliosis: tethered cord.
- Headache, vomiting, drowsiness in a child with a shunt: shunt malfunction.
Treatment
Clean intermittent catheterization and medications
- Clean intermittent catheterization: 4–6 times a day. It empties the bladder completely and reduces pressure and the risk of infection. The parents learn it first, then the child.
- Antimuscarinic medications (for example, oxybutynin): reduce pressure and increase capacity in an overactive detrusor. Side effects such as constipation, dry mouth and heat intolerance are monitored.
- If oral oxybutynin causes side effects, the intravesical form or another antimuscarinic can be chosen.
- If catheterization is not possible in an infant or the family cannot carry it out, a temporary vesicostomy may be considered.
Treatment
When medication is not enough
| Intervention | Goal |
|---|---|
| Botulinum toxin injection into the detrusor | Reduce pressure; effect lasts about 6–9 months, repeated |
| Bladder augmentation (often with ileum) | Increase capacity, reduce pressure |
| Mitrofanoff appendicovesicostomy | Easy catheterization through the umbilicus, independence |
| Bladder neck procedures | Achieve dryness with sphincter weakness |
In a child with an augmented bladder, abdominal pain and fever are a surgical emergency until perforation is ruled out. Over the long term, stones, mucus, metabolic acidosis and B12 deficiency are monitored.
Treatment
Bowel management and general care
- Constipation and fecal incontinence are almost always present and worsen bladder function.
- Stepwise approach: diet and laxatives, transanal irrigation, and if needed an antegrade continence enema channel (MACE/Malone).
- The risk of latex allergy is high: latex-free materials are used for all procedures, and this is noted in the medical record.
- In adolescence: sexual health, fertility and a planned transition to adult care (see the transitional urology course).
The pediatrician's role: refer the newborn with spina bifida to a pediatric urologist in the first weeks, do not treat asymptomatic bacteriuria, treat constipation actively, recognize red flags, and keep communication open within the team.
Quiz
Quiz: Neurogenic bladder
Test yourself: choose one answer.
-
What is the main goal of urologic management in a child with spina bifida?
The main goal is protecting the kidneys from a high-pressure bladder. Dryness is a secondary goal.
-
A 6-year-old on catheterization has bacteria and leukocytes in the urine, with no fever or other symptoms. What should be done?
This is asymptomatic bacteriuria. Treatment is of no benefit and increases resistance.
-
Which urodynamic finding means high risk for the upper urinary tract?
A high detrusor leak point pressure and low compliance are associated with pressure transmission to the upper urinary tract and a risk of kidney damage.
-
A 10-year-old with spina bifida who was previously dry between catheterizations now has increased wetting and a change in gait. What should be considered?
A change in bladder function and neurologic status suggests a tethered cord. Assessment by a pediatric urologist and a neurosurgeon is needed.
-
When is a urodynamic study usually performed in a newborn with spina bifida?
In the proactive approach, urodynamics is performed in the first months so that a high-risk bladder is detected early and treatment is started.
Course completed
Related articles for parents
Sources
- EAU Guidelines on Paediatric Urology, 2025: Management of neurogenic bladder.
- Bauer SB, Austin PF, Rawashdeh YF, et al. International Children’s Continence Society’s recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 2012;31(5):610–614.
- Rawashdeh YF, Austin P, Siggaard C, et al. International Children’s Continence Society’s recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 2012;31(5):615–620.
This material is intended for medical professionals and is based on current clinical guidelines. Decisions about an individual patient are made by the treating doctor.